Abstract:A 17-year-old female Korean patient (XP115KO) was previously diagnosed with Xeroderma pigmentosum group C (XPC) by Direct Sanger sequencing, which revealed a homozygous nonsense mutation in the XPC gene (rs121965088: c.1735C > T, p.Arg579Ter). While rs121965088 is associated with a poor prognosis, our patient presented with a milder phenotype. Hence, we conducted whole-exome sequencing in the patient and her family members to detect coexisting mutations that may have resulted in a milder phenotype of rs121965088 through genetic interaction. Materials and Methods: the whole-exome sequencing analysis of samples obtained from the patient and her family members (father, mother, and brother) was performed. To identify the underlying genetic cause of XPC, the extracted DNA was analyzed using Agilent's SureSelect XT Human All Exon v5. The functional effects of the resultant variants were predicted using the SNPinfo web server, and structural changes in the XPC protein using the 3D protein modeling program SWISS-MODEL. Results: Eight biallelic variants, homozygous in the patient and heterozygous in her parents, were detected. Four were found in the XPC gene: one nonsense variant (rs121965088: c.1735C > T, p.Arg579Ter) and three silent variants (rs2227998: c.2061G > A, p. Arg687Arg; rs2279017: c.2251-6A > C, intron; rs2607775: c.-27G > C, 5'UTR). The remaining four variants were found in non-XP genes, including one frameshift variant [rs72452004 of olfactory receptor family 2 subfamily T member 35 (OR2T35)], three missense variants [rs202089462 of ALF transcription elongation factor 3 (AFF3), rs138027161 of TCR gamma alternate reading frame protein (TARP), and rs3750575 of annexin A7 (ANXA7)]. Conclusions: potential candidates for genetic interactions with rs121965088 were found. The rs2279017 and rs2607775 of XPC involved mutations in the intron region, which affected RNA splicing and protein translation. The genetic variants of AFF3, TARP, and ANXA7 are all frameshift or missense mutations, inevitably disturbing the translation and function of the resultant proteins. Further research on their functions in DNA repair pathways may reveal undiscovered cellular relationships within xeroderma pigmentosum.

Identification of Four Novel XPC Mutations in Two Xeroderma Pigmentosum Complementation Group C Patients and Functional Study of XPC Q320X Mutant.

491 Identification of Four Novel XPC Mutations in Two Xeroderma Pigmentosum Complementation Group C Patients and Functional Study of XPC Q320X Mutant

Identification Of A Novel Nonsense Mutation In Polh In A Chinese Pedigree With Xeroderma Pigmentosum, Variant Type

XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms

Whole Exome Sequencing of a Patient with a Milder Phenotype of Xeroderma Pigmentosum Group C

Identification of a novel protein truncating mutation p.Asp98* in XPC associated with xeroderma pigmentosum in a consanguineous Pakistani family

XPC Polymorphism Increases Risk of Digestive System Cancers： Current Evidence from A Meta-Analysis

Compound Nonsense Mutations of XPAC Gene in One Patient with Xeroderma Pigmentosum Group A

A novel XPD mutation in a compound heterozygote; the mutation in the second allele is present in three homozygous patients with mild sun sensitivity

A novel missense variant and multiexon deletion causing a delayed presentation of xeroderma pigmentosum, group C

Expansion of the genotypic and phenotypic spectrum of xeroderma pigmentosum in Chinese population.

Genotype-phenotype Correlation of Xeroderma Pigmentosum in a Chinese Han Population.

Structural modeling and analyses of genetic variations in the human XPC nucleotide excision repair protein

XPC beyond nucleotide excision repair and skin cancers

Clinical and Molecular Epidemiological Study of Xeroderma Pigmentosum in China: A Case Series of 19 Patients

Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations

Dna-Based Prenatal Diagnosis In A Chinese Family With Xeroderma Pigmentosum Group A

Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies

Xeroderma pigmentosum--bridging a gap between clinic and laboratory

Deep intronic founder mutations identified in the ERCC4/ XPF gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum

Molecular analysis of glioma and skin-tumour alterations in a xeroderma-pigmentosum child